Multi-omics based characterization of antibiotic response in clinical isogenic isolates of methicillin-susceptible/-resistant Staphylococcus aureus
Open Access
- 27 July 2020
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 10 (46) , 27864-27873
Abstract
As demands for new antibiotics and strategies to control methicillin-resistant Staphylococcus aureus (MRSA) increase, there have been efforts to obtain more accurate and abundant information about the mechanism of the bacterial responses to antibiotics. However, most of the previous studies have investigated responses to antibiotics without considering the genetic differences between MRSA and methicillin-susceptible S. aureus (MSSA). Here, we initially applied a multi-omics approach into the clinical isolates (i.e., S. aureus WKZ-1 (MSSA) and S. aureus WKZ-2 (MRSA)) that are isogenic except for the mobile genetic element called staphylococcal cassette chromosome mec (SCCmec) type IV to explore the response to β-lactam antibiotics (oxacillin). First, the isogenic pair showed a similar metabolism without oxacillin treatment. The quantitative proteomics demonstrated that proteins involved in peptidoglycan biosynthesis (MurZ, PBP2, SgtB, PrsA), two-component systems (VrsSR, WalR, SaeSR, AgrA), oxidative stress (MsrA1, MsrB), and stringent response (RelQ) were differentially regulated after the oxacillin treatment of the isogenic isolates. In addition, targeted metabolic profiling showed that metabolites belonging to the building blocks (lysine, glutamine, acetyl-CoA, UTP) of peptidoglycan biosynthesis machinery were specifically decreased in the oxacillin-treated MRSA. These results indicate that the difference in metabolism of this isogenic pair with oxacillin treatment could be caused only by SCCmec type IV. Understanding and investigating the antibiotic response at the molecular level can, therefore, provide insight into drug resistance mechanisms and new opportunities for antibiotics development.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2017M3A9B6062989, NRF-2017M3A9E4077235, NRF-2018R1D1A1B07048185, NRF-2019M2C8A2058418, NRF-2020R1A6A1A03044977)
- Korea Health Industry Development Institute (HP20C0210)
This publication has 43 references indexed in Scilit:
- Inhibitors of Reactive Oxygen Species Accumulation Delay and/or Reduce the Lethality of Several Antistaphylococcal AgentsAntimicrobial Agents and Chemotherapy, 2012
- The WalKR System Controls Major Staphylococcal Virulence Genes and Is Involved in Triggering the Host Inflammatory ResponseInfection and Immunity, 2012
- Oxidation of the Guanine Nucleotide Pool Underlies Cell Death by Bactericidal AntibioticsScience, 2012
- Methicillin Resistance Reduces the Virulence of Healthcare-Associated Methicillin-Resistant Staphylococcus aureus by Interfering With the agr Quorum Sensing SystemThe Journal of Infectious Diseases, 2012
- Expression of Four Methionine Sulfoxide Reductases inStaphylococcus aureusInternational Journal of Microbiology, 2012
- Andromeda: A Peptide Search Engine Integrated into the MaxQuant EnvironmentJournal of Proteome Research, 2011
- The penicillin-binding proteins: structure and role in peptidoglycan biosynthesisFEMS Microbiology Reviews, 2008
- Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substancesNature Protocols, 2008
- The VraS/VraR two-component regulatory system required for oxacillin resistance in community-acquired methicillin-resistantStaphylococcus aureusFEMS Microbiology Letters, 2006
- Penicillin-Binding Proteins and the Antibacterial Effectiveness of β-Lactam AntibioticsClinical Infectious Diseases, 1986